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Summary Pyoderma gangrenosum is a severe neutrophilic dermatosis that may occur as a
complication following any kind of surgery. Although mainly reported secondary to breast
surgery, it may also arise in orthopedic surgery. Misdiagnosis risks serious sequelae, due to
inappropriate or delayed treatment. Unlike the infections, which it mimics, it is to be managed
by corticosteroids, and debridement is absolutely contraindicated, as it will cause dermatologic
lesions in the traumatized areas, worsening and accelerating the pathologic process. As anato-
mopathology tends to shed little light, it is essential to bear the diagnosis in mind in case of any
early superﬁcial pustular lesion showing rapid extension despite correctly administered antibio-
therapy. We report a case of pyoderma gangrenosum secondary to hip replacement surgery, and
detail diagnostic factors and means of treatment.
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yoderma gangrenosum, ﬁrst described in 1930 by Brun-
ting et al. [1], is a rare form of inﬂammatory, aseptic,
lcerative neutrophilic dermatosis. In 50 to 70% of cases,
t precedes or accompanies an underlying inﬂammatory,
mmunologic or neoplastic systemic disorder; it may, how-
ver, also arise secondarily to trauma, including surgery
2], mimicking operative site infection. Although most often
ssociated with breast surgery [3], it may also, more rarely,
ollow orthopedic surgery [4—6].
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bservation
e report a case of pyoderma gangrenosum secondary to
otal hip replacement (THR) performed for arthritis in a
5-year-old woman. She had been operated on 10 years pre-
iously for adenocarcinoma of the colon and 5 years later
or adenocarcinoma of the pancreas, without complications.
he most recent digestive checkups suggested no recurrence
t either site.
THR used an anterior approach with a traction table.
ight days postoperatively, the patient’s temperature was
7.8 ◦C, with a 1× 2 cm pustular lesion in the mid-part of
3he scar showing polynucleosis with a 16,000/mm leukocyte
ount and a CRP value of 214.
A diagnosis of early infection was considered; surface
wabs were taken and hip puncture under ultrasound guid-
nce was performed. Medical and theater records testiﬁed
served.
Pyoderma gangrenosum following an orthopedic surgical procedure 601
F
h
a
2
w
w
ﬂ
t
t
D
P
c
1
a
[Figure 1 Anterior scar, 8 days postoperatively.
to adherence to skin preparation procedures and prophy-
lactic antibiotherapy and instrument and implant sterility.
Amoxicillin/clavulanic acid (Augmentin®) and ciproﬂoxacin
(Ciﬂox®) were administered by precaution awaiting bacte-
riological results, due to the worsening of the skin lesions
at 36 hours (Fig. 1). The unusual, fulminating aspect, neg-
ative bacteriological ﬁndings and strict adherence to good
practice during THR cautioned against early reintervention.
Clinical evolution at 5 days showed 38 ◦C fever, a severe bio-
logical inﬂammatory syndrome (CRP > 300) and, above all,
continued worsening of the ulcerative skin lesion coated in
whitish pus, rounded in form with up to 15 cm diameter,
centered on the anterior part of the scar and threatening
the labia majora (Fig. 2). Given the negative bacterio-
logical ﬁndings and on dermatological advice, a diagnosis
of pyoderma gangrenosum was considered, despite lack of
®evidence from the biopsy. Per os prednisone (Cortancyl )
1mg/kg immediately halted progression; temperature and
biological inﬂammation values returned to normal within
12 days. Given this rapid clinical improvement, the initial
Figure 2 Scar’s aspect at maximum pyoderma gangrenosum
evolution, causing an ulcerative lesion with whitish aseptic
coating.
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cigure 3 Aspect at 2 months postoperatively, following scar
ealing.
ntibiotherapy was replaced by minocycline (Mynocine®)
00mg/day as adjuvant. Prednisone was continued for 6
eeks. Complete healing (Fig. 3) was obtained at 6 weeks
ithout functional sequelae, despite the proximity to the
exion folds. At 2 years’ follow-up, evolution was satisfac-
ory, biological values were normal and the patient was able
o walk freely without pain.
iscussion
yoderma gangrenosum is a rare but threatening compli-
ation of any kind of surgery. Wadia et al. [7] found only
8 publications on the subject in a Medline search of 1300
rticles. Although most often associated with breast surgery
5], pyoderma gangrenosum may occur after any surgical
peration, mimicking early infection.
Unlike early infection, however, pyoderma gangrenosum
equires high-dose corticosteroids or cyclosporine (Neoral®)
5], and debridement is to be at all costs avoided: reproduc-
ng the lesions throughout the traumatized area, it would
ggravate and accelerate evolution in a typical pathergic
esponse [2].
Anatomopathology sheds little light [2], the lesions being
ostly atypical.
A diagnosis of pyoderma gangrenosum is to be considered
n case of early lesions spreading despite preventive antibio-
herapy [8], especially where there is severe inﬂammatory
yndrome, negative bacteriological ﬁndings and associated
ystemic disorder (Crohn’s disease, polyarthritis, diverti-
ulitis, familial history of pyoderma, or immunologic or
eoplastic pathology). Anatomopathology contributes little,
lthough there will typically be an ulcerative lesion with
olynuclear neutrophil inﬁltrate and associated capillary
etwork disorder (mainly, venular thrombosis) [9]. Symptom
ggravation despite correct antibiotherapy is the principal
larm signal. Early diagnosis allows rapid implementation of
orticotherapy, which will both be the decisive diagnostic
est and induce rapid sequela-free resolution [4]. Finally,
reoperative preventive corticotherapy has been reported
o be effective [4—10] in patients with a history of this
omplication.
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